Academic Programmes
Pharmacotherapy of POCS with reference to obesity – CME by Novo
Pharmacotherapy of POCS with reference to obesity at CME by Novo, 5TH JULY,2026.
Academic Programmes
Academic Programmes
One Choice, Multiple Wins: Semaglutide as First-Line Therapy in T2D – CME by Novo
One Choice, Multiple Wins: Semaglutide as First-Line Therapy in T2D at CME by Novo, 30 June 2026.
Academic Programmes
Beyond GLP-1 RAs: Mounjaro – A Class of Its Own – CME by Lilly
Beyond GLP-1 RAs: Mounjaro – A Class of Its Own at CME by Lilly, 29 June 2026.
Academic Programmes
From Base to Peak: Approaching the Obesity Mountain with Tirzepatide – CME by Cipla
From Base to Peak: Approaching the Obesity Mountain with Tirzepatide at CME by Cipla, 27 June 2026.
Academic Programmes
From Glycemic Challenges to Practical Solutions – CME by Eris
From Glycemic Challenges to Practical Solutions at CME by Eris, 26 June 2026.
Academic Programmes
Innovator Semaglutide 2.4 mg: A Benchmark Therapy for Chronic Weight Management – CME by Novo (Wegovy)
Innovator Semaglutide 2.4 mg: A Benchmark Therapy for Chronic Weight Management at CME by Novo (Wegovy), 23 June 2026.
Academic Programmes
Advancing T2DM Management with Innovative Fixed Ratio Combination – CME by Sanofi
Advancing T2DM Management with Innovative Fixed Ratio Combination at CME by Sanofi, 22 June 2026.
Academic Programmes
Healthy Aging: How to Stay Independent, Active & Sharp After 60 – Yoga Day Health Talk
Healthy Aging: How to Stay Independent, Active & Sharp After 60 at Yoga Day Health Talk, 21 June 2026.
Academic Programmes
PANEL DISCUSSION: PRACTICAL INSIGHTS & MYTHS VS FACTS ON SEMAGLUTIDE ROLE: PANELIST – HAD 2026, NAGPUR
PANEL DISCUSSION: PRACTICAL INSIGHTS & MYTHS VS FACTS ON SEMAGLUTIDE ROLE: PANELIST at HAD 2026, NAGPUR, 20 June 2026.
Academic Programmes
The Decade of Metabolic Renaissance – DCTCON 2026,TRICHY
The Decade of Metabolic Renaissance at DCTCON 2026,TRICHY, 13 June 2026.
Academic Programmes
Ozempic Evidence Dialogue – CME by Novo
Ozempic Evidence Dialogue at CME by Novo, 5 June 2026.
Academic Programmes
Mounjaro: A Unified Strategy for Metabolic Disease – CME by Lilly
Mounjaro: A Unified Strategy for Metabolic Disease at CME by Lilly, 30 May 2026.
